An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
EBV causes human B-cell lymphomas and transforms B cells in vitro. EBNA3C, an EBV protein expressed in latently-infected cells, is required for EBV transformation of B cells in vitro. While EBNA3C undoubtedly plays a key role in allowing EBV to successfully infect B cells, many EBV+ lymphomas do not...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-08-01
|
Series: | PLoS Pathogens |
Online Access: | http://europepmc.org/articles/PMC6117096?pdf=render |
_version_ | 1818911801326174208 |
---|---|
author | James C Romero-Masters Makoto Ohashi Reza Djavadian Mark R Eichelberg Mitch Hayes Jillian A Bristol Shidong Ma Erik A Ranheim Jenny Gumperz Eric C Johannsen Shannon C Kenney |
author_facet | James C Romero-Masters Makoto Ohashi Reza Djavadian Mark R Eichelberg Mitch Hayes Jillian A Bristol Shidong Ma Erik A Ranheim Jenny Gumperz Eric C Johannsen Shannon C Kenney |
author_sort | James C Romero-Masters |
collection | DOAJ |
description | EBV causes human B-cell lymphomas and transforms B cells in vitro. EBNA3C, an EBV protein expressed in latently-infected cells, is required for EBV transformation of B cells in vitro. While EBNA3C undoubtedly plays a key role in allowing EBV to successfully infect B cells, many EBV+ lymphomas do not express this protein, suggesting that cellular mutations and/or signaling pathways may obviate the need for EBNA3C in vivo under certain conditions. EBNA3C collaborates with EBNA3A to repress expression of the CDKN2A-encoded tumor suppressors, p16 and p14, and EBNA3C-deleted EBV transforms B cells containing a p16 germline mutation in vitro. Here we have examined the phenotype of an EBNAC-deleted virus (Δ3C EBV) in a cord blood-humanized mouse model (CBH). We found that the Δ3C virus induced fewer lymphomas (occurring with a delayed onset) in comparison to the wild-type (WT) control virus, although a subset (10/26) of Δ3C-infected CBH mice eventually developed invasive diffuse large B cell lymphomas with type III latency. Both WT and Δ3C viruses induced B-cell lymphomas with restricted B-cell populations and heterogeneous T-cell infiltration. In comparison to WT-infected tumors, Δ3C-infected tumors had greatly increased p16 levels, and RNA-seq analysis revealed a decrease in E2F target gene expression. However, we found that Δ3C-infected tumors expressed c-Myc and cyclin E at similar levels compared to WT-infected tumors, allowing cells to at least partially bypass p16-mediated cell cycle inhibition. The anti-apoptotic proteins, BCL2 and IRF4, were expressed in Δ3C-infected tumors, likely helping cells avoid c-Myc-induced apoptosis. Unexpectedly, Δ3C-infected tumors had increased T-cell infiltration, increased expression of T-cell chemokines (CCL5, CCL20 and CCL22) and enhanced type I interferon response in comparison to WT tumors. Together, these results reveal that EBNA3C contributes to, but is not essential for, EBV-induced lymphomagenesis in CBH mice, and suggest potentially important immunologic roles of EBNA3C in vivo. |
first_indexed | 2024-12-19T23:04:28Z |
format | Article |
id | doaj.art-c3fda3f7c3d4491fbf1a5a3453f92f24 |
institution | Directory Open Access Journal |
issn | 1553-7366 1553-7374 |
language | English |
last_indexed | 2024-12-19T23:04:28Z |
publishDate | 2018-08-01 |
publisher | Public Library of Science (PLoS) |
record_format | Article |
series | PLoS Pathogens |
spelling | doaj.art-c3fda3f7c3d4491fbf1a5a3453f92f242022-12-21T20:02:25ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742018-08-01148e100722110.1371/journal.ppat.1007221An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.James C Romero-MastersMakoto OhashiReza DjavadianMark R EichelbergMitch HayesJillian A BristolShidong MaErik A RanheimJenny GumperzEric C JohannsenShannon C KenneyEBV causes human B-cell lymphomas and transforms B cells in vitro. EBNA3C, an EBV protein expressed in latently-infected cells, is required for EBV transformation of B cells in vitro. While EBNA3C undoubtedly plays a key role in allowing EBV to successfully infect B cells, many EBV+ lymphomas do not express this protein, suggesting that cellular mutations and/or signaling pathways may obviate the need for EBNA3C in vivo under certain conditions. EBNA3C collaborates with EBNA3A to repress expression of the CDKN2A-encoded tumor suppressors, p16 and p14, and EBNA3C-deleted EBV transforms B cells containing a p16 germline mutation in vitro. Here we have examined the phenotype of an EBNAC-deleted virus (Δ3C EBV) in a cord blood-humanized mouse model (CBH). We found that the Δ3C virus induced fewer lymphomas (occurring with a delayed onset) in comparison to the wild-type (WT) control virus, although a subset (10/26) of Δ3C-infected CBH mice eventually developed invasive diffuse large B cell lymphomas with type III latency. Both WT and Δ3C viruses induced B-cell lymphomas with restricted B-cell populations and heterogeneous T-cell infiltration. In comparison to WT-infected tumors, Δ3C-infected tumors had greatly increased p16 levels, and RNA-seq analysis revealed a decrease in E2F target gene expression. However, we found that Δ3C-infected tumors expressed c-Myc and cyclin E at similar levels compared to WT-infected tumors, allowing cells to at least partially bypass p16-mediated cell cycle inhibition. The anti-apoptotic proteins, BCL2 and IRF4, were expressed in Δ3C-infected tumors, likely helping cells avoid c-Myc-induced apoptosis. Unexpectedly, Δ3C-infected tumors had increased T-cell infiltration, increased expression of T-cell chemokines (CCL5, CCL20 and CCL22) and enhanced type I interferon response in comparison to WT tumors. Together, these results reveal that EBNA3C contributes to, but is not essential for, EBV-induced lymphomagenesis in CBH mice, and suggest potentially important immunologic roles of EBNA3C in vivo.http://europepmc.org/articles/PMC6117096?pdf=render |
spellingShingle | James C Romero-Masters Makoto Ohashi Reza Djavadian Mark R Eichelberg Mitch Hayes Jillian A Bristol Shidong Ma Erik A Ranheim Jenny Gumperz Eric C Johannsen Shannon C Kenney An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. PLoS Pathogens |
title | An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. |
title_full | An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. |
title_fullStr | An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. |
title_full_unstemmed | An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. |
title_short | An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. |
title_sort | ebna3c deleted epstein barr virus ebv mutant causes b cell lymphomas with delayed onset in a cord blood humanized mouse model |
url | http://europepmc.org/articles/PMC6117096?pdf=render |
work_keys_str_mv | AT jamescromeromasters anebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT makotoohashi anebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT rezadjavadian anebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT markreichelberg anebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT mitchhayes anebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT jillianabristol anebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT shidongma anebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT erikaranheim anebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT jennygumperz anebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT ericcjohannsen anebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT shannonckenney anebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT jamescromeromasters ebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT makotoohashi ebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT rezadjavadian ebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT markreichelberg ebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT mitchhayes ebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT jillianabristol ebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT shidongma ebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT erikaranheim ebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT jennygumperz ebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT ericcjohannsen ebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel AT shannonckenney ebna3cdeletedepsteinbarrvirusebvmutantcausesbcelllymphomaswithdelayedonsetinacordbloodhumanizedmousemodel |